Summary
In 40 patients with TNM stage T1 ovarian clear cell adenocarcinoma, we used nuclear morphometry to study the relations among morphometric variables, clinical prognostic factors and outcome. The presence of one or more giant nuclear cells was positively associated with death (OR = 10.6, P = 0.02) and tended to be associated with disease recurrence (OR = 5.1, P = 0.07). Nuclear irregularity (expressed in terms of the nuclear roundness factor) was positively associated with both death (OR = 8.6, P = 0.02) and disease recurrence (OR = 8.2, P = 0.02). A combination of giant nuclear cell presence or nuclear irregularity proved to be a useful prognostic indicator, with a sensitivity and specificity of 83% and 71% in the prediction of death, and 75% and 71% in the prediction of disease recurrence. Patients’ age and substage were of no prognostic value. We conclude that the nuclear morphometric characteristics, especially the presence of giant nuclear cells and nuclear irregularity, may be useful in predicting outcome in patients with early stage ovarian clear cell adenocarcinoma.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baak, J. A., Schipper, N. W., Wisse-Brekelmans, E. C. M., Ceelen, T., Bosman, F. T., van Geuns, H. & Wils, J. (1988). The prognostic value of morphometrical features and cellular DNA content in cis-platin-treated late ovarian cancer patients. Br J Cancer 57: 503–508.
Benda, J. A. & Zaino, R. (1994). Histologic classification of tumours of the ovary. In GOG Pathology Manual. Gynecologic Oncology Group
Borland, R. N., Partin, A. W., Epstein, J. I. & Brendler, C. B. (1993). The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma. J Urol 149: 272–275.
Christopherson, W. M., Alberhasky, R. C. & Connelly, P. J. (1982). Carcinoma of the endometrium. 1. A clinicopathologic study of clear cell carcinoma and secretory carcinoma. Cancer 49: 1511–1523.
Colombel, M., Delaunoit, Y., Bellot, J., Kiss, R., Abbou, C. & Chopin, D. (1995). Prognostic evaluation of morphonuclear parameters in superficial and invasive bladder cancer. Br J Urol 75: 364–369.
Dembo, A. J., Davy, M., Stenwig, A. E. & Bush, R. S. (1990). Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 75: 263–273.
Diamond, D. A., Berry, S. J., Jewett, H. J., Egglesston, J. C. & Coffey, D. S. (1984). A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness factor. J Urol 128: 729–734.
Finn, C. B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, J. A. & Wilson, S. (1992). Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br J Obstet Gynecol 99: 54–58.
Fuhrman, S. A., Lasky, L. C. & Limas, C. (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655–663.
Fukuzawa, S., Hashimura, T., Sasaki, Yamabe, H. & Yoshida, O. (1995). Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma. Cancer 76: 1790–1796.
Gahlinger, P. M. & Abramson, J. H. (1995). Computer programs for epidemiologic analysis: PEPI. USD Inc: Stone Mountain, GA
Goff, B. A., Cuesta, R. S., Muntz, H. G., Fleischhacker, D., Ek, M., Rice, L. W., Nikrui, N., Tamimi, H. K., Cain, J. M., Green, B. E. & Fuller, A. F. (1996). Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60: 412–417.
Haapasalo, H., Collan, Y., Seppa, A., Gidlund, A-L, Atkin, N. B. & Pesonen, E. (1990). Prognostic value of ovarian carcinoma grading methods – a method comparison study. Histopathology 16: 1–7.
Haapasalo, H., Atkin, N. B., Collan, Y., Pesonen, E. & Paljrvi, L. (1991). Tumour ploidy, morphometry, histological and clinical features in ovarian carcinoma: mutual relations. Anal Cell Pathol 3: 261–271.
Jenison, E. L., Montag, A. G., Griffiths, C. T., Welch, W. R., Lavin, P. T., Greer, J. & Knapp, R. C. (1989). Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serious carcinoma. Gynecol Oncol 32: 65–71.
Kennedy, A. W., Biscotti, C. V., Hart, W. R. & Webster, K. D. (1989). Ovarian clear cell adenocarcinoma. Gynecol Oncol 32: 342–349.
Kennedy, A. W., Biscotti, C. V., Hart, W. R. & Tauson, L. J. (1993). Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma. Gynecol Oncol 50: 334–338.
Klotz, J. K. & Cheung, Y. K. A linked list for the Wilcoxon signed rank test. (in press) J Nonparametric Stat,
Miller, B. E., Lavia, L. A. & Horbelt, D. V. (1991). The prognostic value of image analysis in ovarian cancer. Cancer 67: 1318–1321.
Montag, A. G., Jenison, E. L., Griffiths, C. T., Welch, W. R., Lavin, P. T. & Knapp, R. C. (1989). Ovarian clear cell carcinoma: a clinicopathologic analysis of 44 cases. Int J Gynecol Pathol 8: 85–96.
Nativ, O., Sabo, E., Raviv, G., Medalia, O., Moskovitz, B. & Goldwasser, B. (1995). The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma. Cancer 76: 1440–1444.
O’Brien, M. E. R., Schofield, J. B., Tan, S., Fryatt, I., Fisher, C. & Wiltshaw, E. (1993). Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 49: 250–254.
Partin, A. W., Walsh, A. C., Pitocock, R. V., Mohler, J. L., Epstein, J. I. & Coffey, D. S. (1989). A comparison of nuclear morphometry and Gleason grades: a predictor of prognosis in stage A2 prostate cancer: a critical analysis. J Urol 142: 1254–1258.
Petru, E., Lahousen, M., Tamussion, K., Pickel, H., Stranzl, H., Stettner, H. & Winter, R. (1994). Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170: 656–662.
Pound, C. R., Partin, A. W., Epstein, J. I., Simons, J. W. & Marshall, F. F. (1993). Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology 42: 243–248.
Rodenburg, C. J., Cornelisse, C. J., Hermans, J. & Fleuren, G. J. (1988). DNA flow cytometry and morphometry as prognostic indications in advanced ovarian cancer: a step forward in predicting the clinical outcome. Gynecol Oncol 29: 176–185.
Serov, S. F., Scully, R. E. & Jobin, L. H. (1973). Histologic typing of ovarian tumours in international histological classification of tumours. World Health Organization, Geneva, No. 9, pp. 37–42
Sharkey, F. E., Pavlak, R. J. & Greiner, A. S. (1983). Morphometric analysis of differentiation in human breast carcinoma. Arch Pathol Lab Med 107: 406–410.
Wagner, T. M. U., Adler, A., Sevelda, P., Asssmann, I., Knepflf, C. F., Czerwenka, K. & Heinzl, H. (1994). Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stage I and II/A) by means of automatic image cytometry. Int J Cancer 56: 167–172.
Williams, D. A. (1988). Test for differences between several small proportions. Appl Stat 37: 421–434.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Liu, C., Sasaki, H., Fahey, M. et al. Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma. Br J Cancer 79, 1736–1741 (1999). https://doi.org/10.1038/sj.bjc.6690276
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690276
Keywords
This article is cited by
-
Clinical and Prognostic Value of the Presence of Irregular Giant Nuclear Cells in pT1 Ovarian Clear Cell Carcinoma
Pathology & Oncology Research (2011)